Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Trinity Biotech ( (TRIB) ) has issued an announcement.
On February 24, 2026, Trinity Biotech plc entered into a Standby Equity Purchase Agreement with YA II PN, Ltd. that gives the company the right, at its discretion, to sell up to $25 million of American Depositary Shares over time, subject to an effective resale registration statement and other conditions. The ADSs, each representing 20 class A ordinary shares, will be issued at a discount to prevailing market volume-weighted average prices, within limits tied to trading volume, a 4.99% ownership cap for the investor, and a $25 million aggregate cap, with the facility running until the earlier of February 24, 2029 or full drawdown and providing a flexible but potentially dilutive funding source for Trinity’s growth initiatives.
The most recent analyst rating on (TRIB) stock is a Hold with a $0.80 price target. To see the full list of analyst forecasts on Trinity Biotech stock, see the TRIB Stock Forecast page.
Spark’s Take on TRIB Stock
According to Spark, TipRanks’ AI Analyst, TRIB is a Neutral.
Overall score is held down primarily by weak financial performance (sharp TTM revenue decline, deep losses, negative equity, and negative free cash flow). Technicals are only mildly supportive with mixed trend signals, and valuation provides limited support due to a negative P/E and no dividend yield data.
To see Spark’s full report on TRIB stock, click here.
More about Trinity Biotech
Trinity Biotech plc is an Ireland-based diagnostics company whose American Depositary Shares trade on the Nasdaq Global Market under the symbol TRIB. The group focuses on in vitro diagnostic products and related technologies, serving hospital, clinical laboratory and research markets through its portfolio of specialty testing solutions.
Average Trading Volume: 3,306,163
Technical Sentiment Signal: Strong Sell
Current Market Cap: $13.97M
For an in-depth examination of TRIB stock, go to TipRanks’ Overview page.